PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01)
机构:[1]Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China[2]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China[3]Hebei Med Univ, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[4]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China[5]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[6]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China[7]Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China[8]Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China[9]Hebei Med Univ, Affiliated Hosp 2, Shijiazhuang, Hebei, Peoples R China[10]Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China[11]Wuhan Univ, Zhongnan Hosp, Wuhan, Peoples R China[12]Sichuan Prov Peoples Hosp, Chengdu, Peoples R China四川省人民医院[13]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China中山大学附属第一医院[14]Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China广东省人民医院[15]Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Peoples R China广东省中医院[16]Peking Univ, Peoples Hosp, Beijing, Peoples R China[17]Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
Clinical Research Promotion Project of Guangzhou Medical University for Building High Level University; Guangzhou High-Level Clinical Key Specialty Construction
第一作者机构:[1]Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China[2]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China[3]Hebei Med Univ, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China[4]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China[5]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China[6]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China[7]Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China[8]Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China[9]Hebei Med Univ, Affiliated Hosp 2, Shijiazhuang, Hebei, Peoples R China[10]Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China[11]Wuhan Univ, Zhongnan Hosp, Wuhan, Peoples R China[12]Sichuan Prov Peoples Hosp, Chengdu, Peoples R China[13]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China[14]Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China[15]Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Peoples R China[16]Peking Univ, Peoples Hosp, Beijing, Peoples R China[17]Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
推荐引用方式(GB/T 7714):
Cui Shu-zhong,Liang Han,Li Yong,et al.PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01)[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):doi:10.1200/JCO.2020.38.15_suppl.4538.
APA:
Cui, Shu-zhong,Liang, Han,Li, Yong,Zhou, Yanbing,Tao, Kaixiong...&Wang, Jiping.(2020).PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA:
Cui, Shu-zhong,et al."PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01)".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)